Forms Processing
PRODUCTS
-
Scientific knowledge to strategize viable and efficient drug and device development pathways to achieve successful outcomes.
-
An optimized and effective Contamination Control Strategy (CCS) helps you organization spend less time cleaning and more time manufacturing. Ecolab Life Sciences experts are dedicated to helping you drive the best possible strategy to meet and exceed the GMO Annex 1 CCS requirements.
-
In pharmaceutical testing, the development and validation of analytical methods are absolute musts when it comes to reliable quality control. Natoli Scientific is at the forefront of offering comprehensive analytical method development and validation services designed to ensure the integrity of your company’s drug formulations. Our expert team develops robust methods tailored for each unique compound, with an approach that emphasizes precision, accuracy, sustainability, and compliance with regulatory standards such as the FDA and ICH guidelines. These methods are meticulously validated to confirm their reliability across a range of analytical parameters including specificity, sensitivity, linearity, and reproducibility.
This validation process is critical for verifying that our methods produce consistent, trustworthy results throughout the product’s lifecycle, thus fostering confidence in the safety and efficacy of pharmaceutical products.
-
Gain confidence in your clinical research data with direct data capture (DDC).
-
With over 130 in-life gene therapy studies completed, Altasciences is a leading expert in gene therapy research, with integrated preclinical and bioanalytical capabilities.
WHITE PAPERS AND CASE STUDIES
-
Flexible Integrations To Reduce Risks And Increase Efficiencies
Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
Proprietary Reactivation Study Demonstrates PFAS Removal And Destruction Expertise
Thermal reactivation of granular activated carbon is a proven and scalable method to achieve >99.9% destruction removal efficiency for PFAS. This process fully restores the carbon for reuse, providing a sustainable solution that breaks the cycle of "forever chemicals."
-
The Untapped Power Of Real-World Data And AI In Pharma Commercialization
Harnessing RWD in commercialization bridges the gap between approval and patient access, equipping companies with actionable intelligence to deliver life-changing therapies to more patients.
-
Designing More Precise Clinical Trials Using AI-Driven Analytics
Clinical trials face staggering failure rates and inefficiencies. Discover how AI and real-world evidence streamline patient recruitment and trial design to help reshape the future of clinical research.
-
Membrane Filter Pore Size Impact On Colony Size, Microbial Recovery
Explore results from a study evaluating the effects of different pore sizes on colony size and microbial recovery using membrane filters.
-
How A Pharma Company Improved Yield By 1.5% In Just Three Months
A pharma company faced a 4% yield drop and variability at a manufacturing facility. Explore how they leveraged an AI-based platform to unify data, pinpoint inefficiencies, and enhance consistency in yields.
-
Navigating The European Market's Regulatory Complexities
Prepare your EU launch strategy with this comprehensive guide detailing what is needed to ensure compliance and efficiency in the EU market.
-
The Latest Trends In The Prevention And Treatment Of Cervical Cancer
What immune checkpoint inhibitors are showing promise in cervical cancer treatments and how are advancements in treatment, paired with additional prevention strategies, improving patient outcomes?
-
Rural Water District Leverages Digital Solutions
Discover how Qatium seamlessly integrated with RWD4's existing SCADA system, enhancing real-time decision-making and operational insights.
-
Impact Of Glycosylation On The Effector Functions Of Monoclonal Antibodies
In an example using rituximab and its biosimilars, explore the significance of minor differences of glycosylation in antibodies and its impact on their properties and functionality.
-
Everest Group Life Sciences eCOA Peak Matrix Assessment 2025
Discover how digital platforms are revolutionizing clinical trials by improving data quality and patient engagement in this comprehensive market assessment.
-
Revolutionizing Lead Service Line Removal: A Milestone For Detroit's Water Infrastructure
Detroit, like many other cities across the U.S., has grappled with a silent threat lurking within its aging water infrastructure: lead service lines. Learn why The Detroit Water and Sewage Department partnered with BlueConduit to help make the lead service line inventory and removal process more efficient than ever before.
NEWS
-
StorONE Integrates IBM Storage Scale (Formerly GPFS) Into Its Enterprise Storage Platform11/12/2025
StorONE, developer of the industry's most efficient storage platform, today announced an integration with IBM Storage Scale (formerly known as GPFS) and the company’s enterprise storage offerings.
-
IDScan.net Expands Cloudbeds Integration Of ParseLink To Streamline Guest Check-In12/2/2025
IDScan.net, a leading provider of identity verification and ID scanning technology, today announced an expanded integration with Cloudbeds, the intelligent unified platform powering hotel growth.
-
Third Millennium Unveils Multi-Technology Readers Combining Card And QR Code Access In One Device10/13/2025
Third Millennium, a provider of access control solutions and part of HID, announces the launch of new RXQR and RXQRK readers — multi-technology access-control devices that integrate high-security RFID card and QR code credentials into a single, elegant unit.
-
ADNEC Group Introduces Smart Parking System To Enhance Visitor Experience At The ADNEC Centre Abu Dhabi6/13/2025
ADNEC Group, a Modon Company, has launched a new smart parking system at ADNEC Centre Abu Dhabi, a project aimed to leverage the experience for the venue’s annual 3 million visitors.
-
Bioxytran Develops A Groundbreaking Treatment To Combat Bird Flu In Egg Laying Chickens Potentially Saving Billions3/12/2025
BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, unveiled a potential game-changer in the fight against Highly Pathogenic Avian Influenza (HPAI), commonly known as Bird Flu.